FDA Sued By Death Row Inmates: Goal to Stop Import of Sodium Thiopental - Consider The Ramifications Here, They’re Not All Good


The Food and Drug Administration (FDA) became the defendant in a civil suit filed this week by six Death Row inmates who face execution in Arizona (3 plaintiffs), California (2 plaintiffs), and Tennessee (1 plaintiff) as they seek a declaratory judgment from the federal judge presiding over the United States District Court for the District of Columbia that it is against federal law for the FDA to allow states to use imported sodium thiopental in their executions -- and that the FDA was wrong to issue its announcement that doing so was okay. No news to the FDA - there was a public meeting last month where the players met to discuss the issue, clearly without resolution (or maybe, the meeting was just a chance for the opponents to eyeball each other).

The Wall Street Journal provides a copy of the newly filed complaint here, if you wish to read the entire pleading.

Please see full article below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Terence Lenamon | Attorney Advertising

Written by:


Terence Lenamon on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.